Form: 8-K

Current report filing

November 1, 2007

8-K: Current report filing

Published on November 1, 2007


 



 
PRESS RELEASE – FOR IMMEDIATE RELEASE

OMEGA ANNOUNCES THIRD QUARTER 2007 FINANCIAL RESULTS; THIRD QUARTER ADJUSTED FFO OF $0.35 PER SHARE; $40 MILLION OF NEW INVESTMENTS

TIMONIUM, MARYLAND – November 1, 2007 – Omega Healthcare Investors, Inc. (NYSE:OHI) today announced its results of operations for the quarter ended September 30, 2007.  The Company also reported Funds From Operations (“FFO”) available to common stockholders for the three months ended September 30, 2007 of $22.0 million or $0.32 per common share.  The $22.0 million of FFO available to common stockholders for the quarter includes a $1.6 million non-cash provision for impairment, $0.5 million of non-cash restricted stock expense, a $0.1 million reduction in the Company’s provision for income taxes and $0.1 million of non-cash consolidation adjustments due to Financial Accounting Standards Board Interpretation No. 46R, Consolidation of Variable Interest Entities (“FIN 46R”).  FFO is presented in accordance with the guidelines for the calculation and reporting of FFO issued by the National Association of Real Estate Investment Trusts (“NAREIT”).  Adjusted FFO was $0.35 per common share for the three months ended September 30, 2007.  Adjusted FFO is a non-GAAP financial measure, which additionally excludes the impact of certain non-cash items and certain items of revenue or expenses, including: a provision for impairment and income taxes , restricted stock expenses and FIN 46R consolidation adjustments.  For more information regarding FFO and adjusted FFO, see the “Funds From Operations” section below.

GAAP NET INCOME

For the three-month period ended September 30, 2007, the Company reported net income of $15.3 million, net income available to common stockholders of $12.9 million, or $0.19 per diluted common share and operating revenues of $39.2 million.  This compares to net income of $14.6 million, net income available to common stockholders of $12.1 million, or $0.20 per diluted common share, and operating revenues of $35.1 million for the same period in 2006.

For the nine-month period ended September 30, 2007, the Company reported net income of $52.1 million, net income available to common stockholders of $44.6 million, or $0.69 per diluted common share and operating revenues of $120.0 million.  This compares to net income of $42.3 million, net income available to common stockholders of $34.8 million, or $0.60 per diluted common share, and operating revenues of $99.4 million for the same period in 2006.

The increases in net income, operating revenues and net income available to common stockholders during the nine-month period ended September 30, 2007 were due primarily to approximately $240 million in new investments made throughout 2006 and 2007, as well as, the impact of an allowance adjustment of $5.0 million, or $0.08 per common share, with respect to straight-line rent recognition recorded in the first quarter of 2007.

THIRD QUARTER 2007 HIGHLIGHTS AND OTHER RECENT DEVELOPMENTS

·  
In October, the Company declared a quarterly common dividend of $0.28 per share, an increase of $0.01 per common share compared to the prior quarter.
·  
On October 16, 2007, the Company announced the reinstatement of the optional cash purchase component of the Company’s Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”).
·  
On July 31, 2007, the Company closed on approximately $40 million of new investments.

THIRD QUARTER 2007 RESULTS

Operating Revenues and Expenses– Operating revenues for the three months ended September 30, 2007 were $39.2 million.  Operating expenses for the three months ended September 30, 2007 totaled $13.5 million, comprised of $9.1 million of depreciation and amortization expense, $2.2 million of general and administrative expenses, a $1.6 million non-cash provision for impairment and $0.5 million of stock-based compensation expense primarily associated with the Company’s issuance of restricted stock and performance grants to executive officers during the second quarter of 2007.

Other Income and Expense– Other income and expense for the three months ended September 30, 2007 was a net expense of $10.5 million and was primarily comprised of $10.1 million of interest expense and $0.5 million of amortization of deferred financing costs.

Provision for Income TaxesDuring the quarter, the Company filed and paid $2.1 million related to its 2006 federal income taxes.  The Company continues to make progress in obtaining a closing agreement with the Internal Revenue Service related to the Advocat related party tenant issue previously disclosed in the Company’s Annual Report of Form 10K for the tax years 2002 through 2006.  In addition, the Company has reversed approximately $132,000 of income tax provision related to estimates that it made regarding the tax liability.  The remaining $3.4 million of previously accrued income tax liability relates to the tax years 2002 through 2005.

Funds From Operations– For the three months ended September 30, 2007, reportable FFO available to common stockholders was $22.0 million, or $0.32 per common share, compared to $19.3 million, or $0.32 per common share, for the same period in 2006.  The $22.0 million of FFO for the quarter includes a $1.6 million non-cash provision for impairment, $0.5 million of non-cash stock-based compensation expense, a $0.1 million reduction in the Company’s provision for income taxes and $0.1 million of non-cash FIN 46R consolidation adjustments.

The $19.3 million of FFO for the three months ended September 30, 2006, includes the impact of: i) $3.6 million of non-cash restricted stock expense primarily associated with the Company’s vesting of performance stock units granted to executive officers during 2004 which were earned in 2006; ii) a $2.7 million accounting gain on the sale of an equity security of another issuer; iii) a $1.8 million non-cash increase in the fair value of a derivative; vi) $0.6 million provision for income taxes; v) $0.3 million of non-cash accretion investment income; and vi) $0.2 million provision for uncollectible accounts receivable.

When excluding the above mentioned non-cash or non-recurring items in 2007 and 2006, adjusted FFO was $24.0 million, or $0.35 per common share, for the three months ended September 30, 2007, compared to $18.9 million, or $0.32 per common share, for the same period in 2006.  For further information, see the attached “Funds From Operations” schedule and notes.

PORTFOLIO DEVELOPMENTS

Litchfield Investment Company, LLC  On July 31, 2007, the Company completed a transaction with Litchfield Investment Company, LLC and its affiliates to purchase five skilled nursing facilities for a total investment of approximately $40 million.  The facilities total 645 beds and are located in Alabama (1), Georgia (2), Kentucky (1) and Tennessee (1).  The Company also provided a $2.5 million loan in the form of a subordinated note as part of the transaction.  Simultaneously with the closing of the purchase transaction, the five facilities were combined into an Amended and Restated Master Lease containing 13 other facilities between the Company and an existing operator, Home Quality Management.  The Amended and Restated Master Lease was extended until July 31, 2017.

Other  During the third quarter of 2007, the Company agreed to restructure a five facility master lease with one of its existing tenants whereby the Company and tenant have agreed to sell three facilities and reduce the annual rent on the master lease by $0.4 million.  Two of the facilities are under contract to be sold, pending licensure, for approximately $2.8 million in cash proceeds which will generate an accounting gain of $0.4 million.  The tenant will continue to pay full rent pursuant to the master lease until the completion of the sale of the two facilities.  Upon completion, the overall annual rent on the master lease will be reduced by $0.4 million.  In addition, the Company has recorded a $1.6 million provision for impairment on the third facility to reduce its carrying value to its estimated fair value.




DIVIDENDS

Common Dividends – On October 16, 2007, the Board of Directors declared a common stock dividend of $0.28 per share to be paid November 15, 2007 to common stockholders of record on October 31, 2007.  At the date of this release, the Company had approximately 68 million outstanding common shares.

 
Series D Preferred Dividends On October 16, 2007, the Board of Directors declared the regular quarterly dividends for the 8.375% Series D Cumulative Redeemable Preferred Stock (“Series D Preferred Stock”) to stockholders of record on October 31, 2007.  The stockholders of record of the Series D Preferred Stock on October 31, 2007 will be paid dividends in the amount of $0.52344 per preferred share on November 15, 2007.  The liquidation preference for our Series D Preferred Stock is $25.00 per share. Regular quarterly preferred dividends for the Series D Preferred Stock represent dividends for the period August 1, 2007 through October 31, 2007.
 

Dividend Reinvestment and Common Stock Purchase Plan On October 16, 2007, the Company announced the reinstatement of the optional cash purchase component of the Plan, effective immediately for investments beginning November 15, 2007.  The Company also announced that the per share purchase discount for both optional cash purchases and dividend reinvestments was reset to 1%.  Existing participants in the Plan have been sent a letter from the Company discussing enrollment status and procedures.  All questions and requests in connection with the Plan should be directed to the Plan’s administrator, Computershare, at (800) 519-3111.

 
2007 ADJUSTED FFO GUIDANCE REVISED
 

The Company has increased its 2007 adjusted FFO guidance to be between $1.37 and $1.38 per diluted share, compared to previous guidance of $1.32 and $1.36 per diluted share.  The increase is primarily due to the $40 million acquisition completed by the Company on July 31, 2007.

The Company's adjusted FFO guidance for 2007 excludes the future impacts of acquisitions, gains and losses from the sale of assets, additional divestitures, certain revenue and expense items, capital transactions and restricted stock amortization expense. A reconciliation of the adjusted FFO guidance to the Company's projected GAAP earnings is provided on a schedule attached to this press release.  The Company may, from time to time, update its publicly announced adjusted FFO guidance, but it is not obligated to do so.

The Company's adjusted FFO guidance is based on a number of assumptions, which are subject to change and many of which are outside the control of the Company.  If actual results vary from these assumptions, the Company's expectations may change.  There can be no assurance that the Company will achieve its projected results.

CONFERENCE CALL

The Company will be conducting a conference call on Thursday, November 1, 2007, at 10 a.m. EST to review the Company’s 2007 third quarter results and current developments.  To listen to the conference call via webcast, log on to www.omegahealthcare.com and click the “earnings call” icon on the Company’s home page.  Webcast replays of the call will be available on the Company’s website for two weeks following the call.

*   *   *   *   *   *

The Company is a real estate investment trust investing in and providing financing to the long-term care industry.  At September 30, 2007, the Company owned or held mortgages on 238 SNFs and assisted living facilities with approximately 27,465 beds located in 27 states and operated by 29 third-party healthcare operating companies.

FOR FURTHER INFORMATION, CONTACT
Bob Stephenson, CFO at (410) 427-1700
________________________

 
This announcement includes forward-looking statements. Actual results may differ materially from those reflected in such forward-looking statements as a result of a variety of factors, including, among other things: (i) uncertainties relating to the business operations of the operators of the Company’s properties, including those relating to reimbursement by third-party payors, regulatory matters and occupancy levels; (ii) regulatory and other changes in the healthcare sector, including without limitation, changes in Medicare reimbursement; (iii) changes in the financial position of the Company’s operators; (iv) the ability of operators in bankruptcy to reject unexpired lease obligations, modify the terms of the Company’s mortgages, and impede the ability of the Company to collect unpaid rent or interest during the pendency of a bankruptcy proceeding and retain security deposits for the debtor's obligations; (v) the availability and cost of capital; (vi) competition in the financing of healthcare facilities; (vii) the Company’s ability to maintain its status as a real estate investment trust and to reach a closing agreement with the Internal Revenue Service with respect to the related party tenant issues described in our Form 10-K filed with the Securities and Exchange Commission on February 23, 2007 (“Form 10-K”); (viii) the impact of the material weakness identified in the management’s report on internal control over financial reporting included in our Form 10-K, including expenses that may be incurred in efforts to remediate such weakness and potential additional costs in preparing and finalizing financial statements in view of such material weakness; and (ix) other factors identified in the Company’s filings with the Securities and Exchange Commission. Statements regarding future events and developments and the Company’s future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements.
 

OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands)

   
September 30,
   
December 31,
 
   
2007
   
2006
 
   
(Unaudited)
       
ASSETS
           
Real estate properties
           
Land and buildings at cost
  $
1,273,657
    $
1,235,679
 
Less accumulated depreciation
    (212,634 )     (187,769 )
Real estate properties – net
   
1,061,023
     
1,047,910
 
Mortgage notes receivable – net
   
31,849
     
31,886
 
     
1,092,872
     
1,079,796
 
Other investments – net
   
16,464
     
22,078
 
     
1,109,336
     
1,101,874
 
Assets held for sale – net
   
3,550
     
4,635
 
Total investments – net
   
1,112,886
     
1,106,509
 
                 
Cash and cash equivalents
   
608
     
729
 
Restricted cash
   
3,698
     
4,117
 
Accounts receivable – net
   
61,768
     
51,194
 
Other assets
   
11,933
     
12,821
 
Total assets
  $
1,190,893
    $
1,175,370
 
                 
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Revolving line of credit
  $
52,000
    $
150,000
 
Unsecured borrowings – net
   
484,718
     
484,731
 
Other long–term borrowings
   
40,995
     
41,410
 
Accrued expenses and other liabilities
   
26,567
     
28,037
 
Income tax liabilities
   
3,441
     
5,646
 
Operating liabilities for owned properties
   
     
92
 
Total liabilities
   
607,721
     
709,916
 
                 
Stockholders’ equity:
               
Preferred stock
   
118,488
     
118,488
 
Common stock and additional paid-in-capital
   
825,495
     
700,177
 
Cumulative net earnings
   
344,824
     
292,766
 
Cumulative dividends paid
    (662,568 )     (602,910 )
Cumulative dividends – redemption
    (43,067 )     (43,067 )
Total stockholders’ equity
   
583,172
     
465,454
 
Total liabilities and stockholders’ equity
  $
1,190,893
    $
1,175,370
 




OMEGA HEALTHCARE INVESTORS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
Unaudited
(in thousands, except per share amounts)

   
Three Months Ended
   
Nine Months Ended
 
   
September 30,
   
September 30,
 
   
2007
   
2006
   
2007
   
2006
 
Revenues
                       
Rental income                                                      
  $
37,113
    $
33,016
    $
114,092
    $
92,643
 
Mortgage interest income                                                      
   
999
     
1,054
     
2,896
     
3,392
 
Other investment income – net                                                      
   
962
     
994
     
2,336
     
2,878
 
Miscellaneous                                                      
   
150
     
42
     
640
     
483
 
Total operating revenues                                                        
   
39,224
     
35,106
     
119,964
     
99,396
 
                                 
Expenses
                               
Depreciation and amortization                                                     
   
9,131
     
8,314
     
26,740
     
23,288
 
General and administrative                                                     
   
2,197
     
2,030
     
7,200
     
6,107
 
Restricted stock expense                                                     
   
545
     
3,639
     
880
     
4,224
 
Provision for impairment on real estate properties
   
1,636
     
-
     
1,636
     
-
 
Provision for uncollectible mortgages, notes and accounts receivable
   
-
     
27
     
-
     
27
 
Total operating expenses                                                        
   
13,509
     
14,010
     
36,456
     
33,646
 
                                 
Income before other income and expense                                                        
   
25,715
     
21,096
     
83,508
     
65,750
 
Other income (expense):
                               
Interest and other investment income                                                     
   
36
     
189
     
134
     
371
 
Interest                                                     
    (10,071 )     (11,190 )     (31,988 )     (30,246 )
Interest – amortization of deferred financing costs
    (500 )     (439 )     (1,459 )     (1,513 )
Interest – refinancing costs                                                     
   
-
     
-
     
-
      (3,485 )
Gain on sale of equity securities                                                     
   
-
     
2,709
     
-
     
2,709
 
Change in fair value of derivatives                                                     
   
-
     
1,764
     
-
     
9,672
 
Total other expense                                                        
    (10,535 )     (6,967 )     (33,313 )     (22,492 )
                                 
Income before gain on assets sold                                                        
   
15,180
     
14,129
     
50,195
     
43,258
 
Gain on assets sold - net                                                        
   
-
     
1,188
     
-
     
1,188
 
Income from continuing operations before income taxes
   
15,180
     
15,317
     
50,195
     
44,446
 
Provision for income taxes                                                        
   
132
      (600 )    
132
      (1,739 )
Income from continuing operations                                                        
   
15,312
     
14,717
     
50,327
     
42,707
 
Discontinued operations                                                        
   
37
      (94 )    
1,731
      (419 )
Net income                                                        
   
15,349
     
14,623
     
52,058
     
42,288
 
Preferred stock dividends                                                        
    (2,480 )     (2,480 )     (7,442 )     (7,442 )
Net income available to common                                                        
  $
12,869
    $
12,143
    $
44,616
    $
34,846
 
                                 
Income per common share:
                               
Basic:
                               
Income from continuing operations                                                     
  $
0.19
    $
0.21
    $
0.66
    $
0.61
 
Net income                                                     
  $
0.19
    $
0.21
    $
0.69
    $
0.60
 
Diluted:
                               
Income from continuing operations                                                     
  $
0.19
    $
0.21
    $
0.66
    $
0.60
 
Net income                                                     
  $
0.19
    $
0.20
    $
0.69
    $
0.60
 
                                 
Dividends declared and paid per common share                                                        
  $
0.28
    $
0.24
    $
0.81
    $
0.71
 
                                 
Weighted-average shares outstanding, basic                                                        
   
67,952
     
59,021
     
65,094
     
58,203
 
Weighted-average shares outstanding, diluted                                                        
   
67,965
     
59,446
     
65,114
     
58,407
 
                                 
Components of other comprehensive income:
                               
Net income                                                        
  $
15,349
    $
14,623
    $
52,058
    $
42,288
 
Unrealized gain on common stock investment
   
-
     
-
     
-
     
1,580
 
Reclassification adjustment for gain on common stock investment
   
-
      (1,740 )    
-
      (1,740 )
Unrealized loss on preferred stock investment
   
-
      (172 )    
-
      (763 )
Total comprehensive income                                                        
  $
15,349
    $
12,711
    $
52,058
    $
41,365
 





OMEGA HEALTHCARE INVESTORS, INC.
FUNDS FROM OPERATIONS
Unaudited
(In thousands, except per share amounts)

   
Three Months Ended
   
Nine Months Ended
 
   
September 30,
   
September 30,
 
   
2007
   
2006
   
2007
   
2006
 
                         
Net income available to common stockholders
  $
12,869
    $
12,143
    $
44,616
    $
34,846
 
Add back loss (deduct gain) from real estate dispositions(1)
   
1
      (1,188 )     (1,595 )     (807 )
Sub-total
   
12,870
     
10,955
     
43,021
     
34,039
 
Elimination of non-cash items included in net income:
                               
Depreciation and amortization(1)
   
9,138
     
8,362
     
26,768
     
23,432
 
Funds from operations available to common stockholders
  $
22,008
    $
19,317
    $
69,789
    $
57,471
 
                                 
Weighted-average common shares outstanding, basic
   
67,952
     
59,021
     
65,094
     
58,203
 
Effect of restricted stock awards
   
     
404
     
3
     
184
 
Assumed exercise of stock options
   
13
     
21
     
17
     
20
 
Weighted-average common shares outstanding, diluted
   
67,965
     
59,446
     
65,114
     
58,407
 
                                 
Fund from operations per share available to common stockholders
  $
0.32
    $
0.32
    $
1.07
    $
0.98
 
                                 
Adjusted funds from operations:
                               
Funds from operations available to common stockholders
  $
22,008
    $
19,317
    $
69,789
    $
57,471
 
Deduct gain from sale of Sun common stock
   
      (2,709 )    
      (2,709 )
Deduct Advocat one-time straight line adjustment
   
     
      (5,040 )    
 
Deduct non-cash increase in fair value of Advocat derivative
   
      (1,764 )    
      (9,672 )
Deduct Advocat non-cash accretion investment income
   
      (329 )    
      (1,155 )
Deduct FIN 46R adjustment
    (77 )    
      (230 )    
 
Deduct /add back provision for income taxes
    (132 )    
600
      (132 )    
1,739
 
Add back non-cash provisions for uncollectible mortgages, notes and accounts receivable
   
     
179
     
     
179
 
Add back one-time non-cash interest refinancing expense
   
     
     
     
3,485
 
Add back non-cash restricted stock expense
   
545
     
3,639
     
880
     
4,224
 
Add back non-cash provision for impairments on real estate properties(1)
   
1,636
     
     
1,636
     
121
 
Adjusted funds from operations available to common stockholders
  $
23,980
    $
18,933
    $
66,903
    $
53,683
 
(1) Includes amounts in discontinued operations

This press release includes Funds From Operations, or FFO, which is a non-GAAP financial measure.  For purposes of the Securities and Exchange Commission’s Regulation G, a non-GAAP financial measure is a numerical measure of a company’s historical or future financial performance, financial position or cash flows that excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable financial measure calculated and presented in accordance with GAAP in the statement of operations, balance sheet or statement of cash flows (or equivalent statements) of the company, or includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable financial measure so calculated and presented.  As used in this press release, GAAP refers to generally accepted accounting principles in the United States of America.  Pursuant to the requirements of Regulation G, the Company has provided reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures.

The Company calculates and reports FFO in accordance with the definition and interpretive guidelines issued by the National Association of Real Estate Investment Trusts ("NAREIT"), and consequently, FFO is defined as net income available to common stockholders, adjusted for the effects of asset dispositions and certain non-cash items, primarily depreciation and amortization.  The Company believes that FFO is an important supplemental measure of its operating performance.  Because the historical cost accounting convention used for real estate assets requires depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time, while real estate values instead have historically risen or fallen with market conditions.  The term FFO was designed by the real estate industry to address this issue.  FFO herein is not necessarily comparable to FFO of other real estate investment trusts, or REITs, that do not use the same definition or implementation guidelines or interpret the standards differently from the Company.

In February 2004, NAREIT informed its member companies that it was adopting the position of the SEC with respect to asset impairment charges and would no longer recommend that impairment write-downs be excluded from FFO.  In the tables included in this press release, the Company has applied this interpretation and has not excluded asset impairment charges in calculating its FFO.  As a result, its FFO may not be comparable to similar measures reported in previous disclosures.  According to NAREIT, there is inconsistency among NAREIT member companies as to the adoption of this interpretation of FFO.  Therefore, a comparison of the Company’s FFO results to another company's FFO results may not be meaningful.

The Company uses FFO as one of several criteria to measure the operating performance of its business.  The Company further believes that by excluding the effect of depreciation, amortization and gains or losses from sales of real estate, all of which are based on historical costs and which may be of limited relevance in evaluating current performance, FFO can facilitate comparisons of operating performance between periods and between other REITs.  The Company offers this measure to assist the users of its financial statements in analyzing its performance; however, this is not a measure of financial performance under GAAP and should not be considered a measure of liquidity, an alternative to net income or an indicator of any other performance measure determined in accordance with GAAP.  Investors and potential investors in the Company’s securities should not rely on this measure as a substitute for any GAAP measure, including net income.

Adjusted FFO is calculated as FFO available to common stockholders less non-cash stock-based compensation and one-time revenue and expense items.  The Company believes that adjusted FFO provides an enhanced measure of the operating performance of the Company’s core portfolio as a REIT.  The Company's computation of adjusted FFO is not comparable to the NAREIT definition of FFO or to similar measures reported by other REITs, but the Company believes it is an appropriate measure for this Company.





The following table presents a reconciliation of our guidance regarding 2007 FFO and Adjusted FFO to net income available to common stockholders:

   
2007 Projected
 
Per diluted share:
                 
Net income available to common stockholders
  $
0.90
     
    $
0.91
 
Adjustments:
                       
Depreciation and amortization
   
0.50
     
     
0.50
 
Funds from operations available to common stockholders
  $
1.40
     
    $
1.41
 
                         
Adjustments:
                       
Advocat straight-line revenue adjustment
    (0.07 )    
      (0.07 )
FIN 46R non-cash revenue adjustment
    (0.00 )    
      (0.00 )
Provision for impairment of real estate assets
   
0.02
     
     
0.02
 
Restricted stock expense
   
0.02
     
     
0.02
 
Adjusted funds from operations available to common stockholders
  $
1.37
     
    $
1.38
 


The following table summarizes the results of operations of assets held for sale and facilities sold during the three and nine months ended September 30, 2007 and 2006, respectively.


   
Three Months Ended
   
Nine Months Ended
 
   
September 30,
   
September 30,
 
   
2007
   
2006
   
2007
   
2006
 
   
(in thousands)
 
Revenues
                       
Rental income
  $
45
    $
138
    $
167
    $
413
 
Expenses
                               
Depreciation and amortization
   
7
     
49
     
28
     
144
 
General and administrative
   
     
31
     
3
     
34
 
Provision for impairment
   
     
     
     
121
 
Allowance for uncollectible loans
   
     
152
     
     
152
 
Subtotal expenses
   
7
     
232
     
31
     
451
 
                                 
Gain (loss) before gain (loss) on sale of assets
   
38
      (94 )    
136
      (38 )
(Loss) gain on assets sold – net
    (1 )    
     
1,595
      (381 )
Discontinued operations
  $
37
    $ (94 )   $
1,731
    $ (419 )






The following tables present selected portfolio information, including operator and geographic concentrations, and revenue maturities for the period ending September 30, 2007.

Portfolio Composition ($000's)
                             
                               
Balance Sheet Data
 
# of Properties
   
# of Beds
   
Investment
   
% Investment
       
Real Property(1)(2)
   
229
     
26,345
    $
1,294,202
      98 %      
Loans Receivable(3)
   
9
     
1,120
     
33,149
      2 %      
Total Investments
   
238
     
27,465
    $
1,327,351
      100 %      
   
Investment Data
 
# of Properties
   
# of Beds
   
Investment
   
% Investment
   
Investment per Bed
 
Skilled Nursing Facilities (1)(3)
   
230
     
26,879
    $
1,273,593
      96 %   $
47
 
Assisted Living Facilities
   
6
     
416
     
30,323
      2 %    
73
 
Rehab Hospitals
   
2
     
170
     
23,435
      2 %    
138
 
     
238
     
27,465
    $
1,327,351
      100 %   $
48
 
                                         
(1) Includes a $19.2 million lease inducement.
(2) Includes 7 buildings worth $61.8 million resulting from a FIN 46R consolidation.
(3) Includes $1.3 million of unamortized principal.
 



Revenue Composition ($000's)
                       
                         
Revenue by Investment Type
 
Three Months Ended
   
Nine Months Ended
 
   
September 30, 2007
   
September 30, 2007
 
Rental Property (1)
  $
37,113
      95 %   $
114,092
      96 %
Mortgage Notes
   
999
      3 %    
2,896
      2 %
Other Investment Income
   
962
      2 %    
2,336
      2 %
    $
39,074
      100 %   $
119,324
      100 %
                                 
Revenue by Facility Type
 
Three Months Ended
   
Nine Months Ended
 
   
September 30, 2007
   
September 30, 2007
 
Assisted Living Facilities
  $
487
      1 %   $
1,479
      1 %
Skilled Nursing Facilities (1)
   
37,625
      96 %    
115,509
      97 %
Other
   
962
      3 %    
2,336
      2 %
    $
39,074
      100 %   $
119,324
      100 %
                                 
(1) Revenue includes $0.8 million and $2.3 million reduction for lease inducements for the three- and nine- month periods ending September 30, 2007, respectively.
 



Operator Concentration ($000's)
                 
                   
Concentration by Investment
 
# of Properties
   
Investment
   
% Investment
 
Sun Healthcare Group, Inc.
   
42
    $
233,323
      18 %
Communicare
   
19
     
193,127
      14 %
Advocat, Inc.
   
39
     
141,836
      11 %
HQM
   
18
     
137,490
      10 %
Haven
   
15
     
117,230
      9 %
Guardian (1)
   
17
     
105,181
      8 %
Remaining Operators
   
88
     
399,164
      30 %
     
238
    $
1,327,351
      100 %
                         
(1) Investment amount includes a $19.2 million lease inducement.
 




                   
Geographic Concentration ($000's)
                 
                   
Concentration by Region
 
# of Properties
   
Investment
   
% Investment
 
South (1)
   
114
    $
562,198
      42 %
Midwest
   
53
     
333,950
      25 %
Northeast
   
37
     
259,157
      20 %
West
   
34
     
172,046
      13 %
     
238
    $
1,327,351
      100 %

Concentration by State
 
# of Properties
   
Investment
   
% Investment
 
Ohio
   
37
    $
278,994
      21 %
Florida
   
25
     
173,092
      13 %
Pennsylvania
   
17
     
110,234
      8 %
Texas
   
21
     
82,532
      6 %
California
   
15
     
60,246
      5 %
Remaining States (1)
   
123
     
622,253
      47 %
     
238
    $
1,327,351
      100 %
(1) Investment amount includes a $19.2 million lease inducement.
 

Revenue Maturities ($000's)
                         
                           
Operating Lease Expirations & Loan Maturities
Year
 
Current Lease Revenue (1)
   
Current Interest Revenue (1)
   
Lease and Interest Revenue
   
%
 
 
2007
   
3,823
     
-
     
3,823
      2 %
 
2008
   
1,071
     
-
     
1,071
      1 %
 
2009
   
-
     
-
     
-
      0 %
 
2010
   
11,210
     
1,445
     
12,655
      9 %
 
2011
   
11,293
     
209
     
11,502
      8 %
 
Thereafter
   
112,075
     
2,121
     
114,196
      80 %
      $
139,472
    $
3,775
    $
143,247
      100 %
                                   
(1) Based on 2007 contractual rents and interest payment obligations (no annual escalators).
 
                                   
Selected Facility Data
                                 
TTM ending 6/30/07
                   
Coverage Data
 
     
% Payor Mix
   
Before
   
After
 
 
Census
 
Private
   
Medicare
   
Mgmt. Fees
   
Mgmt. Fees
 
All Healthcare Facilities
82.5%
    11.5 %     13.9 %    
2.2 x
     
1.7 x
 
                                   
                                   

The following tables present selected financial information, including leverage and interest coverage ratios, as well as a debt maturity schedule for the period ending September 30, 2007.

             
Current Capitalization ($000's)
           
   
Outstanding Balance
   
%
 
Borrowings Under Bank Lines
  $
52,000
      4.5 %
Long-Term Debt Obligations (1)
   
525,995
      45.3 %
Stockholders’ Equity
   
583,172
      50.2 %
Total Book Capitalization
  $
1,161,167
      100.0 %
                 
(1) Excludes net discount of $0.3 million on unsecured borrowings. Includes $39.0 million of additional debt due to required FIN 46R consolidation.
 
                 
Leverage & Performance Ratios
               
Debt / Total Book Cap
    49.8 %        
Debt / Total Market Cap
    33.1 %        
Interest Coverage:
               
3rd quarter 2007
   
3.51 x
         




Debt Maturities ($000's)
   
Secured Debt
                   
 
Year
 
Lines of Credit (1)
   
FIN 46R Consolidation
   
Other
   
Senior Notes
   
Total
 
 
2007
  $
-
    $
-
    $
-
    $
-
    $
-
 
 
2008
   
-
     
-
     
435
     
-
     
435
 
 
2009
   
-
     
-
     
465
     
-
     
465
 
 
2010
   
255,000
     
-
     
495
     
-
     
255,495
 
 
Thereafter
   
-
     
39,000
     
600
     
485,000
     
524,600
 
      $
255,000
    $
39,000
    $
1,995
    $
485,000
    $
780,995
 
                                           
 
(1) Reflected at 100% capacity.
                 
   


The following table presents investment activity for the three- and nine- month periods ending September 30, 2007.


                         
Investment Activity ($000's)
                       
   
Three Months Ended
   
Nine Months Ended
 
   
September 30, 2007
   
September 30, 2007
 
   
$ Amount
   
%
   
$ Amount
   
%
 
Funding by Investment Type:
                       
  Real Property
  $
39,500
      97 %   $
39,500
      90 %
  Mortgages
   
-
      0 %    
345
      1 %
  Other
   
1,402
      3 %    
4,173
      9 %
    Total
  $
40,902
      100 %   $
44,018
      100 %